Iron Status in Patients With Chronic Left Ventricular Systolic Failure

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 130

فایل این مقاله در 5 صفحه با فرمت PDF قابل دریافت می باشد

این مقاله در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IEJM-11-2_008

تاریخ نمایه سازی: 3 آبان 1401

چکیده مقاله:

Background: Heart failure is one of the most important public health problems with an increasing prevalence and identifying its contributing factors is imperative. This study was conducted to evaluate the iron status in patients with chronic systolic heart failure in Shahid Mohammadi Hospital of Bandar Abbas.Materials and Methods: A total of ۸۰ patients with chronic left ventricular failure participated in this cross-sectional study. Data were collected using a researcher developed checklist containing demographic details and echocardiographic data (left ventricular ejection fraction, LVEF%). Additionally, the frequency and distribution of iron status were measured in the research population.Results: The results showed that the prevalence of anemia was significantly high in patients with chronic heart failure (۷۷.۳%). The prevalence of iron deficiency (ID) was ۷۷.۳۳% based on iron level ( < ۶۰ μg/dL), and it was ۸۲.۶۶% based on the mean ferritin level (ferritin < ۱۰۰, or ferritin of ۱۰۰ to ۲۹۹ ng/mL, and transferrin saturation < ۲۰%). The prevalence of total iron binding capacity (TIBC) > ۳۶۰ μg/dL was ۲۶.۶۶%, and the prevalence of mean corpuscular volume (MCV) < ۸۰ fL was ۶۰%. Age less than ۶۰ years, glomerular filtration rate (GFR) less than ۶۰, and body mass index (BMI) less than ۱۸.۵ were also found to increase the risk of anemia in these patients.Conclusion: Our study showed that the prevalence of anemia was significantly high in patients with chronic heart failure. Due to the high prevalence of anemia in patients with chronic systolic heart failure and the impact of anemia on the prognosis of the disease in these patients, effective treatment is necessary in high-risk patients to reduce the severity of their disease, compensate for their heart failure, and reduce their mortality.

کلیدواژه ها:

نویسندگان

Mitra Kazmi Jahromi

نویسنده اول

Fatemeh Nikparvar

نویسنده دوم

Mansooreh Hoghooghi

نویسنده سوم

Shima Minaee

نویسنده چهارم

Marzieh Nikparvar

نویسنده پنجم

Elham Boushehri

نویسنده مسئول